Response to COVID-19: A Mid-sized CRO Perspective is a position paper written by Cheryle Evans, our SVP of Clinical Operations, North America, highlighting the implications of the COVID-19 pandemic on the clinical industry. Learn the latest on new regulations that have been established by both the FDA and EMA in response, as well as an overview of common sponsor challenges and how Advanced Clinical is modifying our operational processes.
